Tag: Biogen

Biogen beats expectations and raises forecast as Alzheimer's drug Leqembi and other latest products gain traction

Biogen on Thursday reported Second-quarter earnings and revenue beat estimates and raised full-year guidance as ...

READ MORE

European Medicines Agency rejects Alzheimer’s drug Leqembi from Biogen and Eisai

European Medicines Agency on Friday rejected the Alzheimer treatment Leqembi from Biogen And Eisaiwhich represents ...

READ MORE